Frank Holms
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
-
- Breast Cancer Treatment Studies 7
- Cancer Genomics and Diagnostics 1
- Oncology 6
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
- Cancer Cells and Metastasis 2
- Cancer Diagnosis and Treatment 1
- Co-authors
- Gϋnter von Minckwitz (4 shared papers)Sibylle Loibl (5 shared papers)Michael Untch (4 shared papers)Hans Tesch (4 shared papers)Iris Schrader (4 shared papers)Jens Huober (3 shared papers)Tanja Natascha Fehm (2 shared papers)J. Hilfrich (2 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Cancer Research (1 paper)JAMA Oncology (1 paper)Annals of Oncology (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- GermanySwitzerlandNetherlands
In The Last Decade
Frank Holms
12 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 49
- Cancer Research 519
- Oncology 802
- Immunology 124
- Pulmonary and Respiratory Medicine 136
- Radiology, Nuclear Medicine and Imaging 65
Countries citing papers authored by Frank Holms
This map shows the geographic impact of Frank Holms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Holms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Holms more than expected).
Fields of papers citing papers by Frank Holms
This network shows the impact of papers produced by Frank Holms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Holms. The network helps show where Frank Holms may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Holms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 430 | |
| 2 | 2013 | 195 | |
| 3 | 2016 | 164 | |
| 4 | 2014 | 110 | |
| 5 | 2017 | 95 | |
| 6 | 2021 | 68 | |
| 7 | 2011 | 46 | |
| 8 | 2022 | 16 | |
| 9 | 2011 | 12 | |
| 10 | 2019 | 8 | |
| 11 | 2017 | 5 | |
| 12 | 2011 | 3 |
About Frank Holms
Frank Holms is a scholar working on Cancer Research, Oncology, Neurology, Radiology, Nuclear Medicine and Imaging and Insect Science, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Cells and Metastasis (2 papers), Cancer Genomics and Diagnostics (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Neurological disorders and treatments (1 paper) and Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (519 citations), Oncology (802 citations), Immunology (124 citations), Pulmonary and Respiratory Medicine (136 citations) and Radiology, Nuclear Medicine and Imaging (65 citations). Frank Holms has collaborated with scholars based in Germany, Switzerland and Netherlands. Frequent co-authors include Gϋnter von Minckwitz, Sibylle Loibl, Michael Untch, Hans Tesch, Iris Schrader, Jens Huober, Tanja Natascha Fehm, J. Hilfrich, Sabine Riethdorf and Klaus Pantel. Their work appears in journals such as Clinical Cancer Research, Cancer Research, JAMA Oncology, Annals of Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.